Doppler tissue imaging: regional myocardial function in hypertrophic cardiomyopathy and in athlete's heart

Nuno Cardim1, A Gouveia Oliveira, Susana Longo

  • 1Department of Cardiology, Hospital Pulido Valente, Lisbon, Portugal. Corclinica@clix.pt

Insights

Doppler tissue imaging reveals distinct regional heart function differences between hypertrophic cardiomyopathy (HCM) patients and athletes. These findings aid in differentiating HCM from the athlete's heart, especially in ambiguous cases.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Sports Cardiology

Background:

  • Differentiating hypertrophic cardiomyopathy (HCM) from the athlete's (AT) heart is clinically significant.
  • Doppler tissue imaging (DTI) offers potential for analyzing regional myocardial function in differential diagnosis.

Purpose of the Study:

  • To compare regional left ventricular (LV) function using DTI in patients with nonobstructive HCM and competitive rowers.
  • To identify specific DTI parameters that distinguish between HCM and the athlete's heart.

Main Methods:

  • Pulsed Doppler tissue imaging analyzed LV regional function in 24 HCM patients and 20 rowers.
  • Evaluated longitudinal and radial myocardial mechanics, including velocities, time intervals, and gradients.
  • Focused on parameters like precontraction period (PCP) and time to peak e velocity.

Main Results:

  • HCM patients exhibited reduced systolic velocities and meridional gradients in both longitudinal and radial axes compared to athletes.
  • Patients with HCM showed prolonged PCP and higher PCP/LV contraction time ratios.
  • Diastolic function differences included lower e and a velocities, longer prerelaxation times, and a higher prevalence of e/a < 1 in HCM patients.

Conclusions:

  • Significant systolic and diastolic regional LV function differences exist between HCM and athletes.
  • These DTI-derived differences are observable in both longitudinal and radial axes, and even in non-hypertrophied segments.
  • DTI is a valuable tool for the differential diagnosis of HCM and athlete's heart, particularly in challenging cases (Maron's 'grey zone').
Abstract